"}

CH-223191 - Moligand™,10mM in DMSO , CAS No.301326-22-7

En stock
SKU
C408298
Articles du produit groupé
Nom du produit Qté
[C408298-1ml] CH-223191
Prix Spécial 135,90 $US Prix normal 175,90 $US

AhR Antagonists

Information

CH-223191 CH-223191 is a potent and specific aryl hydrocarbon receptor (AhR) antagonist with IC50 of 30 nM.
In vitro

CH-223191 blocks TCDD-mediated nuclear translocation and DNA binding of AhR, and also causes the inhibition of TCDD-induced cytochrome P450 enzyme activity. In human glioblastoma cells, CH-223191downregulates the TGF-beta/Smad pathway, and reduces clonogenic survival and invasiveness. In SK-N-SH human-derived neuronal cells, CH223191 counteracts the TCDD-induced suppression of neuronal acetylcholinesterase expression. In endothelial cells, CH-223191 potentiates ICAM-1 expression and prevents RelB nuclear translocation.

In vivo

CH-223191 (10 mg/kg/day, p.o.) potently prevents TCDD-caused cytochrome P450 induction, liver toxicity, and wasting syndrome in mice.
Cell Data

cell lines:PAE

Concentrations:

Incubation Time:

Powder Purity:≥99%

Plus d’information

Plus d’information
CAS301326-22-7
Concentration10mM in DMSO
Synonymes2-methyl-N-[2-methyl-4-[(2-methylphenyl)diazenyl]phenyl]pyrazole-3-carboxamide
Spécifications et puretéMoligand™,10mM in DMSO
Conditions de stockage de stockageStore at -80°C
Expédié enDry ice packs + Cold packs
Product Description

Information

CH-223191 CH-223191 is a potent and specific aryl hydrocarbon receptor (AhR) antagonist with IC50 of 30 nM.
In vitro

CH-223191 blocks TCDD-mediated nuclear translocation and DNA binding of AhR, and also causes the inhibition of TCDD-induced cytochrome P450 enzyme activity. In human glioblastoma cells, CH-223191downregulates the TGF-beta/Smad pathway, and reduces clonogenic survival and invasiveness. In SK-N-SH human-derived neuronal cells, CH223191 counteracts the TCDD-induced suppression of neuronal acetylcholinesterase expression. In endothelial cells, CH-223191 potentiates ICAM-1 expression and prevents RelB nuclear translocation.

In vivo

CH-223191 (10 mg/kg/day, p.o.) potently prevents TCDD-caused cytochrome P450 induction, liver toxicity, and wasting syndrome in mice.
Cell Data

cell lines:PAE

Concentrations:

Incubation Time:

Powder Purity:≥99%

Numéro CE683-682-8
Formule moléculaireC19H19N5O

Avis

Avis des clients

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.

Copyright © 2023-present Aladdin Scientific Corp All rights reserved.